Filing Details
- Accession Number:
- 0001209191-15-049383
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-06-03 11:53:26
- Reporting Period:
- 2015-06-01
- Filing Date:
- 2015-06-03
- Accepted Time:
- 2015-06-03 11:53:26
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1293971 | Bluebird Bio Inc. | BLUE | Biological Products, (No Disgnostic Substances) (2836) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1578432 | H. Mitchell Finer | C/O Bluebird Bio, Inc. 150 Second Street Cambridge MA 02141 | Chief Scientific Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2015-06-01 | 15,000 | $24.47 | 15,000 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-06-01 | 4,842 | $188.59 | 10,158 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2015-06-01 | 1,593 | $189.25 | 8,565 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2015-06-01 | 3,106 | $190.57 | 5,459 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2015-06-01 | 4,022 | $191.42 | 1,437 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2015-06-01 | 813 | $192.36 | 624 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2015-06-01 | 375 | $193.31 | 249 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2015-06-01 | 83 | $194.35 | 166 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2015-06-01 | 166 | $195.07 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2015-06-01 | 15,000 | $0.00 | 15,000 | $24.47 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 40,000 | 2024-03-03 | No | 4 | M | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 22, 2014.
- The range of prices for the transaction reported on this line was $188.22 to $188.99. The average weighted price was $188.5856. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The range of prices for the transaction reported on this line was $189.13 to $189.50. The average weighted price was $189.2530. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The range of prices for the transaction reported on this line was $190.00 to $190.91. The average weighted price was $190.5689. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The range of prices for the transaction reported on this line was $191.01 to $191.93. The average weighted price was $191.4193. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The range of prices for the transaction reported on this line was $192.00 to $192.64. The average weighted price was $192.3605. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The range of prices for the transaction reported on this line was $193.00 to $193.75. The average weighted price was $193.3133. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The range of prices for the transaction reported on this line was $194.35 to $194.35. The average weighted price was $194.3500. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The range of prices for the transaction reported on this line was $195.01 to $195.12. The average weighted price was $195.0650. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- This option vests over a four-year period, at the rate of twenty-five percent (25%) on January 1, 2015, and in 36 equal monthly installments thereafter.
Billionaire Hedge Funds
